Original price was: $1,000.00.$699.00Current price is: $699.00.
In Stock
Molnupiravir (Lagevrio) is intended for the treatment of mild to moderate COVID 19 in adult patients (over 18 years of age):
• If the direct test for the SARS-CoV-2 virus is positive
• At high risk of developing severe COVID-19, including hospitalization or death, in cases where other options
treatments for COVID-19 are either unavailable or inappropriate clinical indicators
Active ingredient: Molnupiravir
Prescription medicine.
